Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drugs

Showing results (301-310 of 8,370) with videos related to

Pageof 837
Sort By:
Drugs|January 1, 1987
Summary of early clinical experience with anisoylated plasminogen streptokinase activator complex in the treatment of acute myocardial infarctionD Jackson
Drugs|January 1, 1987
Achievement of coronary artery patency by use of anisoylated plasminogen streptokinase activator complex in acute myocardial infarctionW S Hillis, R S Hornung, K J Hogg, et al.
Drugs|January 1, 1987
Anisoylated plasminogen streptokinase activator complex versus streptokinase in acute myocardial infarction. Preliminary results of a randomised studyP Monnier, U Sigwart, A Vincent, et al.
Drugs|January 1, 1987
Intracoronary streptokinase versus intravenous anisoylated plasminogen streptokinase activator complex in the treatment of acute myocardial infarctionL Kaspar, R Karnik, E Sehnal, et al.
Drugs|January 1, 1987
Electrocardiographic and enzymatic infarct size in a randomised study of intracoronary streptokinase and intravenous anisoylated plasminogen streptokinase activator complex in acute myocardial infarctionR A Hackworthy, S G Sorensen, R L Menlove, et al.
Drugs|January 1, 1987
Fibrinogen concentration and coronary artery reperfusion after intravenous anisoylated plasminogen streptokinase activator complex or intracoronary streptokinase therapyV J Marder, P A Kinsella, M J Brown
Drugs|January 1, 1987
Systemic effects of anisoylated plasminogen streptokinase activator complex and streptokinase therapy in acute myocardial infarction. Coagulation aspects of the Dutch Invasive Reperfusion StudyJ J Hoffmann, J J Bonnier, J B de Swart, et al.
Drugs|January 1, 1987
Anisoylated plasminogen streptokinase activator complex versus placebo. A preliminary multicentre study of safety and early mortality in acute myocardial infarctionD G Julian, L S Borthwick, D Reid, et al.
Drugs|January 1, 1987
Safety and side effects of anisoylated plasminogen streptokinase activator complex and streptokinase in patients with acute myocardial infarction. Interim report of the IRS II StudyJ P Monassier, M Hanssen
Drugs|January 1, 1987
Preliminary safety and tolerance data obtained in the comparative study of anisoylated plasminogen streptokinase activator complex versus heparinE A Croydon
Pageof 837

Showing results (301-310 of 8,370) with videos related to

Sort By:
Pageof 837
Drugs|January 1, 1987
Summary of early clinical experience with anisoylated plasminogen streptokinase activator complex in the treatment of acute myocardial infarctionD Jackson
Drugs|January 1, 1987
Achievement of coronary artery patency by use of anisoylated plasminogen streptokinase activator complex in acute myocardial infarctionW S Hillis, R S Hornung, K J Hogg, et al.
Drugs|January 1, 1987
Anisoylated plasminogen streptokinase activator complex versus streptokinase in acute myocardial infarction. Preliminary results of a randomised studyP Monnier, U Sigwart, A Vincent, et al.
Drugs|January 1, 1987
Intracoronary streptokinase versus intravenous anisoylated plasminogen streptokinase activator complex in the treatment of acute myocardial infarctionL Kaspar, R Karnik, E Sehnal, et al.
Drugs|January 1, 1987
Electrocardiographic and enzymatic infarct size in a randomised study of intracoronary streptokinase and intravenous anisoylated plasminogen streptokinase activator complex in acute myocardial infarctionR A Hackworthy, S G Sorensen, R L Menlove, et al.
Drugs|January 1, 1987
Fibrinogen concentration and coronary artery reperfusion after intravenous anisoylated plasminogen streptokinase activator complex or intracoronary streptokinase therapyV J Marder, P A Kinsella, M J Brown
Drugs|January 1, 1987
Systemic effects of anisoylated plasminogen streptokinase activator complex and streptokinase therapy in acute myocardial infarction. Coagulation aspects of the Dutch Invasive Reperfusion StudyJ J Hoffmann, J J Bonnier, J B de Swart, et al.
Drugs|January 1, 1987
Anisoylated plasminogen streptokinase activator complex versus placebo. A preliminary multicentre study of safety and early mortality in acute myocardial infarctionD G Julian, L S Borthwick, D Reid, et al.
Drugs|January 1, 1987
Safety and side effects of anisoylated plasminogen streptokinase activator complex and streptokinase in patients with acute myocardial infarction. Interim report of the IRS II StudyJ P Monassier, M Hanssen
Drugs|January 1, 1987
Preliminary safety and tolerance data obtained in the comparative study of anisoylated plasminogen streptokinase activator complex versus heparinE A Croydon
Pageof 837